News
To date, the Endangered Species Act has been the country’s key weapon in the fight against extinction. While the law’s protection mechanisms have helped rescue nearly 300 species from going the way of ...
Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results